{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:57:26Z","timestamp":1761947846081},"reference-count":46,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.3892\/or.2012.2066","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T07:00:58Z","timestamp":1349074858000},"page":"1953-1958","source":"Crossref","is-referenced-by-count":12,"title":["Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor"],"prefix":"10.3892","volume":"28","author":[{"given":"KOSEI","family":"NAKAJIMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"YANAGAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEOMI","family":"WATANABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENJI","family":"TAKAGISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,1]]},"reference":[{"key":"key20180107215928_b1-or-28-06-1953","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180107215928_b2-or-28-06-1953","article-title":"Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials","author":"Whelan","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180107215928_b3-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/cncr.21724","article-title":"Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution","volume":"106","author":"Bacci","year":"2006","journal-title":"Cancer"},{"key":"key20180107215928_b4-or-28-06-1953","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1200\/JCO.2004.00.5785","article-title":"Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups","volume":"23","author":"Ferrari","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107215928_b5-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"key20180107215928_b6-or-28-06-1953","doi-asserted-by":"crossref","first-page":"32165","DOI":"10.1074\/jbc.M304537200","article-title":"Regulation of cell proliferation by autocrine motility factor\/phosphoglucose isomerase signaling","volume":"278","author":"Tsutsumi","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107215928_b7-or-28-06-1953","first-page":"3507","article-title":"Purification of B16-F1 melanoma autocrine motility factor and its receptor","volume":"51","author":"Silletti","year":"1991","journal-title":"Cancer Res"},{"key":"key20180107215928_b8-or-28-06-1953","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01753982","article-title":"Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma","volume":"12","author":"Watanabe","year":"1994","journal-title":"Clin Exp Metastasis"},{"key":"key20180107215928_b9-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1006\/bbrc.2001.4912","article-title":"Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility","volume":"284","author":"Funasaka","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107215928_b10-or-28-06-1953","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ijc.10617","article-title":"Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells","volume":"101","author":"Funasaka","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107215928_b11-or-28-06-1953","first-page":"242","article-title":"Overexpression of the autocrine motility factor\/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts","volume":"63","author":"Tsutsumi","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107215928_b12-or-28-06-1953","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ijc.11449","article-title":"Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression","volume":"107","author":"Haga","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107215928_b13-or-28-06-1953","first-page":"2960","article-title":"Tumor cell autocrine motility factor is the neuroleukin\/phosphohexose isomerase polypeptide","volume":"56","author":"Watanabe","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107215928_b14-or-28-06-1953","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/332455a0","article-title":"Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3\u2032 sequences","volume":"332","author":"Faik","year":"1988","journal-title":"Nature"},{"key":"key20180107215928_b15-or-28-06-1953","first-page":"2667","article-title":"Expression and secretion of neuroleukin\/phosphohexose isomerase\/maturation factor as autocrine motility factor by tumor cells","volume":"58","author":"Niinaka","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107215928_b16-or-28-06-1953","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.3700057","article-title":"Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta","volume":"84","author":"Yanagawa","year":"2004","journal-title":"Lab Invest"},{"key":"key20180107215928_b17-or-28-06-1953","doi-asserted-by":"crossref","first-page":"10419","DOI":"10.1074\/jbc.M409457200","article-title":"Differential regulation of phosphoglucose isomerase\/autocrine motility factor activities by protein kinase CK2 phosphorylation","volume":"280","author":"Yanagawa","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107215928_b18-or-28-06-1953","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/07357909009012053","article-title":"The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer","volume":"8","author":"Baumann","year":"1990","journal-title":"Cancer Invest"},{"key":"key20180107215928_b19-or-28-06-1953","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000217737","article-title":"Serum phosphohexose isomerase activities in patients with colorectal cancer","volume":"12","author":"Filella","year":"1991","journal-title":"Tumour Biol"},{"key":"key20180107215928_b20-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/1097-0142(195411)7:6<1200::AID-CNCR2820070612>3.0.CO;2-9","article-title":"Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast","volume":"7","author":"Bodansky","year":"1954","journal-title":"Cancer"},{"key":"key20180107215928_b21-or-28-06-1953","first-page":"271","article-title":"Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer","volume":"42","author":"Patel","year":"1995","journal-title":"Neoplasma"},{"key":"key20180107215928_b22-or-28-06-1953","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/path.1878","article-title":"Autocrine motility factor\/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours","volume":"208","author":"Dobashi","year":"2006","journal-title":"J Pathol"},{"key":"key20180107215928_b23-or-28-06-1953","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1158\/0008-5472.CAN-09-3880","article-title":"Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis","volume":"70","author":"Niinaka","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107215928_b24-or-28-06-1953","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1470-2045(10)70071-1","article-title":"Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study","volume":"11","author":"Issels","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20180107215928_b25-or-28-06-1953","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jbm.a.33229","article-title":"In vitro evaluation of glass-glass ceramic thermoseed-induced hyperthermia on human osteosarcoma cell line","volume":"100","author":"Alcaide","year":"2012","journal-title":"J Biomed Mater Res A"},{"key":"key20180107215928_b26-or-28-06-1953","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/cbf.1371","article-title":"Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells","volume":"25","author":"Trieb","year":"2007","journal-title":"Cell Biochem Funct"},{"key":"key20180107215928_b27-or-28-06-1953","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1359\/jbmr.2001.16.4.731","article-title":"Mild heat shock induces proliferation, alkaline phosphatase activity, and mineralization in human bone marrow stromal cells and Mg-63 cells in vitro","volume":"16","author":"Shui","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key20180107215928_b28-or-28-06-1953","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1302\/0301-620X.92B4.22814","article-title":"Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model","volume":"92","author":"Shido","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"key20180107215928_b29-or-28-06-1953","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijc.20611","article-title":"Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin","volume":"113","author":"Bagatell","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107215928_b30-or-28-06-1953","doi-asserted-by":"crossref","first-page":"41439","DOI":"10.1074\/jbc.M507209200","article-title":"Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation","volume":"280","author":"Shin","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107215928_b31-or-28-06-1953","first-page":"2942","article-title":"Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells","volume":"60","author":"Yokota","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107215928_b32-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/1078-0432.CCR-06-1892","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study","volume":"13","author":"Bagatell","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107215928_b33-or-28-06-1953","first-page":"797","article-title":"Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90","volume":"29","author":"Koga","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107215928_b34-or-28-06-1953","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/bbrc.1999.1637","article-title":"Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion","volume":"265","author":"Sato","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107215928_b35-or-28-06-1953","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1158\/0008-5472.CAN-06-3935","article-title":"Down-regulation of phosphoglucose isomerase\/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells","volume":"67","author":"Funasaka","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107215928_b36-or-28-06-1953","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1158\/0008-5472.CAN-09-0488","article-title":"Phosphoglucose isomerase\/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer","volume":"69","author":"Funasaka","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107215928_b37-or-28-06-1953","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004390050849","article-title":"Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency","volume":"103","author":"Kugler","year":"1998","journal-title":"Hum Genet"},{"key":"key20180107215928_b38-or-28-06-1953","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1158\/0008-5472.CAN-07-1586","article-title":"Regulation of phosphoglucose isomerase\/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14","volume":"67","author":"Yanagawa","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107215928_b39-or-28-06-1953","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9610(99)00117-8","article-title":"Hyperthermic isolated regional perfusion for the treatment of osteosarcoma in the lower extremity","volume":"178","author":"Nakano","year":"1999","journal-title":"Am J Surg"},{"key":"key20180107215928_b40-or-28-06-1953","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1119(01)00460-7","article-title":"The minisatellite of the GPI\/AMF\/NLK\/MF gene: interspecies conservation and transcriptional activity","volume":"269","author":"Williams","year":"2001","journal-title":"Gene"},{"key":"key20180107215928_b41-or-28-06-1953","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1096\/fj.05-3699com","article-title":"Regulation of phosphoglucose isomerase\/autocrine motility factor expression by hypoxia","volume":"19","author":"Funasaka","year":"2005","journal-title":"FASEB J"},{"key":"key20180107215928_b42-or-28-06-1953","first-page":"89","article-title":"Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?","volume":"1816","author":"Khalil","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180107215928_b43-or-28-06-1953","article-title":"Targeting heat shock proteins in cancer","author":"Jego","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107215928_b44-or-28-06-1953","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2336::AID-CNCR7>3.0.CO;2-J","article-title":"Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis","volume":"79","author":"Uozaki","year":"1997","journal-title":"Cancer"},{"key":"key20180107215928_b45-or-28-06-1953","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/00313025.2010.493866","article-title":"Expression of heat shock proteins in osteosarcomas","volume":"42","author":"Moon","year":"2010","journal-title":"Pathology"},{"key":"key20180107215928_b46-or-28-06-1953","first-page":"2325","article-title":"Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study","volume":"52","author":"T\u00eatu","year":"1992","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2066\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:59:42Z","timestamp":1515362382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,10,1]]},"published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.3892\/or.2012.2066"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2066","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,1]]}}}